Too big, too small: selecting hematoma sizes for inclusion in intracerebral hemorrhage-deferoxamine trials.
作者信息
Ye Fenghui, Wan Yingfeng, Koduri Sravanthi, Holste Katherine G, Keep Richard F, Hua Ya, Xi Guohua
机构信息
Department of Neurosurgery, University of Michigan, R5018 Biomedical Science Research Building, 109 Zina Pitcher Place, Ann Arbor, MI, 48109-2200, USA.
出版信息
Transl Stroke Res. 2023 Jun;14(3):281-282. doi: 10.1007/s12975-022-01013-8. Epub 2022 Mar 28.
Abstract
摘要
相似文献
1
Too big, too small: selecting hematoma sizes for inclusion in intracerebral hemorrhage-deferoxamine trials.太大，太小：选择纳入脑出血-去铁胺试验的血肿大小
Transl Stroke Res. 2023 Jun;14(3):281-282. doi: 10.1007/s12975-022-01013-8. Epub 2022 Mar 28.
2
Deferoxamine reduces neuronal death and hematoma lysis after intracerebral hemorrhage in aged rats.去铁胺可减少老年大鼠脑出血后的神经元死亡和血肿溶解。
Transl Stroke Res. 2013 Oct;4(5):546-53. doi: 10.1007/s12975-013-0270-5.
3
Deferoxamine in intracerebral hemorrhage: Systematic review and meta-analysis.去铁胺治疗脑出血：系统评价和荟萃分析。
Clin Neurol Neurosurg. 2023 Apr;227:107634. doi: 10.1016/j.clineuro.2023.107634. Epub 2023 Feb 20.
4
The combination of deferoxamine and minocycline strengthens neuroprotective effect on acute intracerebral hemorrhage in rats.去铁胺与米诺环素联合使用可增强对大鼠急性脑出血的神经保护作用。
Neurol Res. 2021 Oct;43(10):854-864. doi: 10.1080/01616412.2021.1939487. Epub 2021 Jun 10.
5
Deferoxamine-induced attenuation of brain edema and neurological deficits in a rat model of intracerebral hemorrhage.去铁胺减轻大鼠脑出血模型中的脑水肿和神经功能缺损
Neurosurg Focus. 2003 Oct 15;15(4):ECP4. doi: 10.3171/foc.2003.15.4.10.
6
Deferoxamine mesylate: a new hope for intracerebral hemorrhage: from bench to clinical trials.甲磺酸去铁胺：脑出血的新希望：从实验室到临床试验
Stroke. 2009 Mar;40(3 Suppl):S90-1. doi: 10.1161/STROKEAHA.108.533125. Epub 2008 Dec 8.
7
Effect of Deferoxamine on Outcome According to Baseline Hematoma Volume: A Post Hoc Analysis of the i-DEF Trial.依基线血肿体积分析去铁胺对结局的影响：i-DEF 试验的事后分析。
Stroke. 2022 Apr;53(4):1149-1156. doi: 10.1161/STROKEAHA.121.035421. Epub 2021 Nov 18.
8
Effect of AMPA receptor antagonist YM872 on cerebral hematoma size and neurological recovery in the intracerebral hemorrhage rat model.AMPA受体拮抗剂YM872对脑出血大鼠模型脑血肿大小及神经功能恢复的影响
Eur J Pharmacol. 2003 Apr 25;467(1-3):95-101. doi: 10.1016/s0014-2999(03)01572-3.
9
The clinical effect of deferoxamine mesylate on edema after intracerebral hemorrhage.甲磺酸去铁胺对脑出血后水肿的临床疗效。
PLoS One. 2015 Apr 13;10(4):e0122371. doi: 10.1371/journal.pone.0122371. eCollection 2015.
10
Deferoxamine-induced attenuation of brain edema and neurological deficits in a rat model of intracerebral hemorrhage.去铁胺减轻大鼠脑出血模型中的脑水肿和神经功能缺损
J Neurosurg. 2004 Apr;100(4):672-8. doi: 10.3171/jns.2004.100.4.0672.
引用本文的文献
1
Surgical Treatment Could Improve Long-Term Functional Outcomes in Intracerebral Hemorrhage Patients With NIHSS ≥ 10.手术治疗可改善美国国立卫生研究院卒中量表（NIHSS）评分≥10分的脑出血患者的长期功能预后。
CNS Neurosci Ther. 2025 Jun;31(6):e70458. doi: 10.1111/cns.70458.
2
The Role of Iron-Chelating Therapy in Improving Neurological Outcome in Patients with Intracerebral Hemorrhage: Evidence-Based Case Report.铁螯合疗法在改善脑出血患者神经预后中的作用：基于证据的病例报告。
Medicina (Kaunas). 2023 Feb 24;59(3):453. doi: 10.3390/medicina59030453.
本文引用的文献
1
Effect of Deferoxamine on Outcome According to Baseline Hematoma Volume: A Post Hoc Analysis of the i-DEF Trial.依基线血肿体积分析去铁胺对结局的影响：i-DEF 试验的事后分析。
Stroke. 2022 Apr;53(4):1149-1156. doi: 10.1161/STROKEAHA.121.035421. Epub 2021 Nov 18.
2
Intracerebral Hemorrhage-Induced Brain Injury in Rats: the Role of Extracellular Peroxiredoxin 2.大鼠脑出血诱导的脑损伤：细胞外过氧化物酶 2 的作用。
Transl Stroke Res. 2020 Apr;11(2):288-295. doi: 10.1007/s12975-019-00714-x. Epub 2019 Jul 4.
3
Deferoxamine mesylate in patients with intracerebral haemorrhage (i-DEF): a multicentre, randomised, placebo-controlled, double-blind phase 2 trial.甲磺酸去铁胺治疗脑出血患者的研究（i-DEF）：一项多中心、随机、安慰剂对照、双盲的 2 期临床试验。
Lancet Neurol. 2019 May;18(5):428-438. doi: 10.1016/S1474-4422(19)30069-9. Epub 2019 Mar 18.
4
Efficacy and safety of minimally invasive surgery with thrombolysis in intracerebral haemorrhage evacuation (MISTIE III): a randomised, controlled, open-label, blinded endpoint phase 3 trial.微创血肿清除术与溶栓治疗脑出血的疗效和安全性（MISTIE III）：一项随机、对照、开放标签、盲终点 3 期试验。
Lancet. 2019 Mar 9;393(10175):1021-1032. doi: 10.1016/S0140-6736(19)30195-3. Epub 2019 Feb 7.
5
Intensive Blood-Pressure Lowering in Patients with Acute Cerebral Hemorrhage.急性脑出血患者的强化血压降低
N Engl J Med. 2016 Sep 15;375(11):1033-43. doi: 10.1056/NEJMoa1603460. Epub 2016 Jun 8.
6
Guidelines for the Management of Spontaneous Intracerebral Hemorrhage: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association.自发性脑出血管理指南：美国心脏协会/美国中风协会医疗保健专业人员指南。
Stroke. 2015 Jul;46(7):2032-60. doi: 10.1161/STR.0000000000000069. Epub 2015 May 28.
7
Rapid blood-pressure lowering in patients with acute intracerebral hemorrhage.急性脑出血患者的血压快速降低。
N Engl J Med. 2013 Jun 20;368(25):2355-65. doi: 10.1056/NEJMoa1214609. Epub 2013 May 29.
8
Intracerebral haemorrhage: mechanisms of injury and therapeutic targets.脑出血：损伤机制和治疗靶点。
Lancet Neurol. 2012 Aug;11(8):720-31. doi: 10.1016/S1474-4422(12)70104-7. Epub 2012 Jun 13.
9
Safety and tolerability of deferoxamine mesylate in patients with acute intracerebral hemorrhage.甲磺酸去铁胺治疗急性脑出血患者的安全性和耐受性。
Stroke. 2011 Nov;42(11):3067-74. doi: 10.1161/STROKEAHA.111.617589. Epub 2011 Aug 25.
10
Recommendations for the management of intracranial haemorrhage - part I: spontaneous intracerebral haemorrhage. The European Stroke Initiative Writing Committee and the Writing Committee for the EUSI Executive Committee.颅内出血管理建议——第一部分：自发性脑出血。欧洲卒中倡议写作委员会及欧洲卒中倡议执行委员会写作委员会
Cerebrovasc Dis. 2006;22(4):294-316. doi: 10.1159/000094831. Epub 2006 Jul 28.
Zotero 插件